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Background
The COVID-19 pandemic has been associated 
with mental health and substance use 
disorder challenges related to effects of the 
disease, but also to the mitigation attempts, 
including but not limited to: isolation due to 
social distancing, loss of jobs and financial 
stresses, and decreases in social support 
structures. The Centers for Disease Control 
reported in a morbidity and mortality weekly 
report that symptoms of anxiety and 
depression increased significantly during  
the pandemic compared with the prior year. 
Adverse effects include worsening mental 
health symptoms, increase in substance use 
as a coping mechanism and suicidality. We 
aimed to evaluate patients presenting with a 
toxic exposure who were also found to have 
COVID-19 infection.
Methods
The ToxIC Core Registry is a multicenter 
database of patients cared for at the 
bedside or via telehealth by medical 
toxicologists. A new set of COVID-19 
specific questions were incorporated into 
the REDCap database on August 1, 2020. 
The ToxIC registry was queried from 
8/2020–12/2020 for all cases, including 
those with reported COVID-19 positive, 
negative, and unknown testing during their 
encounter. COVID-19 positive cases were 
compared to COVID-19 negative and 
unknown cases. Descriptive analysis was 
performed for variables including age, sex, 
and reason for exposure.
Conclusion 
During the last 5 months of 2020, fewer 
than 2% of cases entered into the ToxIC 
Registry were COVID-19 positive. COVID-19 
negative patients were more likely to have 
intentional pharmaceutical exposures as  




From 3,119 toxicological exposure cases 
submitted after the implementation of new 
COVID-19 specific questions, 51 cases (1.6%) 
were positive for COVID-19, 1,397 (44.8%) 
were negative, and 1,671 (53.6%) had 
unknown status of COVID-19 during that 
encounter. Of the 51 COVID-19 positive 
cases, males accounted for 55% (N=28)  
and females accounted for 45% (N=23). 
Comparing COVID-19 positive cases (N=51) 
and COVID-19 negative cases (N=1,397), the 
most common reason for encounter for 
each group was intentional pharmaceutical 
exposure (56% and 51% respectively). 
However, intentional pharmaceutical 
exposures reported as attempt at self-harm 
was 61.5% for COVID-19 positive and 76.1% 
for COVID-19 negative patients. In the group 
of 51 patients presenting with an exposure 
who were COVID-19 positive, 5 (9.8%) 
exposures were related to COVID-19 
treatment or prophylaxis.
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